Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M164,924Revenue (TTM) $M39,907Net Margin (%)13.8Altman Z-Score3.4
Enterprise Value $M177,213EPS (TTM) $2.0Operating Margin %19.6Piotroski F-Score7
P/E(ttm)30.7Beneish M-Score-2.6Pre-tax Margin (%)17.1Higher ROA y-yN
Price/Book3.810-y EBITDA Growth Rate %4.7Quick Ratio1.6Cash flow > EarningsY
Price/Sales4.25-y EBITDA Growth Rate %9.2Current Ratio1.9Lower Leverage y-yN
Price/Free Cash Flow18.0y-y EBITDA Growth Rate %-41.1ROA % (ttm)5.5Higher Current Ratio y-yY
Dividend Yield %3.1PEG3.5ROE % (ttm)12.4Less Shares Outstanding y-yY
Payout Ratio %94.0Shares Outstanding M2,757ROIC % (ttm)11.3Gross Margin Increase y-yY

Gurus Latest Trades with MRK

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
MRKKen Fisher 2016-12-31 Reduce$58.43 - $64.96
($61.33)
$ 60.33-2%Reduce -0.22%6,802,264
MRKBarrow, Hanley, Mewhinney & Strauss 2016-09-30 Reduce-0.7%$57.65 - $63.86
($61.28)
$ 60.33-2%Reduce -29.93%18,581,032
MRKVanguard Health Care Fund 2016-09-30 Reduce-0.61%$57.65 - $63.86
($61.28)
$ 60.33-2%Reduce -10.72%41,516,228
MRKDodge & Cox 2016-09-30 Reduce-0.34%$57.65 - $63.86
($61.28)
$ 60.33-2%Reduce -24.80%18,327,311
MRKJoel Greenblatt 2016-09-30 Reduce-0.14%$57.65 - $63.86
($61.28)
$ 60.33-2%Reduce -38.77%330,785
MRKKahn Brothers 2016-09-30 Reduce-0.08%$57.65 - $63.86
($61.28)
$ 60.33-2%Reduce -0.72%957,991
MRKCharles Brandes 2016-09-30 Reduce-0.07%$57.65 - $63.86
($61.28)
$ 60.33-2%Reduce -2.75%2,812,318
MRKT Rowe Price Equity Income Fund 2016-09-30 Reduce-0.03%$57.65 - $63.86
($61.28)
$ 60.33-2%Reduce -3.57%3,375,000
MRKKen Fisher 2016-09-30 Add0.01%$57.65 - $63.86
($61.28)
$ 60.33-2%Add 0.86%6,817,544
MRKTweedy Browne 2016-09-30 Buy 0.01%$57.65 - $63.86
($61.28)
$ 60.33-2%New holding3,306
MRKMario Gabelli 2016-09-30 Reduce$57.65 - $63.86
($61.28)
$ 60.33-2%Reduce -5.37%107,405
MRKRichard Pzena 2016-09-30 Reduce$57.65 - $63.86
($61.28)
$ 60.33-2%Reduce -0.47%1,408,678
MRKRuane Cunniff 2016-09-30 Sold Out $57.65 - $63.86
($61.28)
$ 60.33-2%Sold Out0
MRKJoel Greenblatt 2016-06-30 Reduce-0.42%$52.91 - $57.68
($55.73)
$ 60.338%Reduce -56.73%540,222
MRKT Rowe Price Equity Income Fund 2016-06-30 Reduce-0.3%$52.91 - $57.68
($55.73)
$ 60.338%Reduce -25.58%3,500,000
MRKVanguard Health Care Fund 2016-06-30 Reduce-0.26%$52.91 - $57.68
($55.73)
$ 60.338%Reduce -4.57%46,499,820
MRKKahn Brothers 2016-06-30 Reduce-0.2%$52.91 - $57.68
($55.73)
$ 60.338%Reduce -2.08%964,925
MRKRichard Pzena 2016-06-30 Add0.18%$52.91 - $57.68
($55.73)
$ 60.338%Add 53.62%1,415,390
MRKCharles Brandes 2016-06-30 Reduce-0.08%$52.91 - $57.68
($55.73)
$ 60.338%Reduce -3.60%2,891,914
MRKTom Gayner 2016-06-30 Buy 0.01%$52.91 - $57.68
($55.73)
$ 60.338%New holding5,600
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MRK is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


MRK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
FRAZIER KENNETH CChairman, President & CEO 2016-11-10Sell140,000$65.03-7.23view
Gerberding Julie L.EVP Strat Comm, Gl Pub Policy 2016-11-07Sell85,523$60.020.52view
LAZARUS ROCHELLE BDirector 2016-11-02Sell20,000$59.062.15view
WENDELL PETER CDirector 2016-11-02Sell5,000$59.51.39view
GRADDICK WEIR MIRIAN MExe V-P, HR 2016-10-03Sell40,800$62.07-2.8view
Schechter Adam HEVP & Pres-Global Human Health 2016-09-01Sell39,200$62.61-3.64view
Golestani ClarkEVP & Chief Info Officer 2016-08-10Sell3,000$63.03-4.28view
FRAZIER KENNETH CChairman, President & CEO 2016-08-05Sell392,000$61.81-2.39view
GRADDICK WEIR MIRIAN MExe V-P, HR 2016-07-05Sell45,000$57.994.04view
FRAZIER KENNETH CChairman, President & CEO 2016-07-05Sell60,000$584.02view

Press Releases about MRK :

Quarterly/Annual Reports about MRK:

News about MRK:

Articles On GuruFocus.com
US Market Indexes Higher After Trump Press Conference Jan 11 2017 
US Market Indexes Trade Flat Jan 10 2017 
Gilead Sciences Must Answer to Investors After a Disappointing 2016 Jan 05 2017 
US Market Indexes Start the New Year Higher Jan 03 2017 
US Market Indexes Lower Dec 28 2016 
US Market Indexes Higher on Tuesday Dec 27 2016 
US Market Indexes Lower on Wednesday Dec 21 2016 
A Tesaro Catalyst the Markets Seem to Have Overlooked Dec 20 2016 
Dodge & Cox Sells Symantec, Walmart, Microsoft Dec 15 2016 
Big Alzheimer Flop Creates Buying Opportunity for Eli Lilly Dec 10 2016 

More From Other Websites
Gilead, Merck, Alexion 2017 Views Hazy; Biogen May Surge: Analyst Jan 19 2017
Merck, Biogen, Lilly Top 2016 Drug Approvals Despite FDA Slump Jan 19 2017
U.S. stocks close lower ahead of Trump inauguration Jan 19 2017
Exxon Mobil, Merck Weigh on DJIA Thursday Jan 19 2017
Merck, Biogen, Lilly Top 2016 Drug Approvals Despite FDA Slump Jan 19 2017
Merck CEO sees Keytruda in pole position in cancer race Jan 19 2017
BioLineRx (BLRX) Starts Cancer Study on BL-8040+Keytruda Jan 19 2017
Bristol-Myers (BMY) Q4 Earnings: Will the Stock Disappoint? Jan 19 2017
MSD for Mothers Commits $10 Million and Business Expertise to the Global Financing Facility to Help... Jan 19 2017
MSD for Mothers Commits $10 Million and Business Expertise to the Global Financing Facility to Help... Jan 19 2017
Merck & Co., Inc. (MRK) And Palantir Technologies Inc Agree On Cancer Data Analysis Pact Jan 18 2017
Merck Foundation Grant Expands Project ECHO® in Vietnam and India Jan 18 2017
AstraZeneca Offers Update on Immuno-Oncology Program Jan 18 2017
Agenus, NCI Ink Deal to Evaluate Prophage-Keytruda Combo Jan 18 2017
Drugmakers in Davos shift focus to chronic diseases of poor Jan 18 2017
[$$] Pfizer warns of 'big challenge' ahead from strong dollar Jan 18 2017
Drugmakers in Davos shift focus to chronic diseases of poor Jan 18 2017
AARP CEO: Trumpcare needs these 4 basic principles Jan 17 2017
Merck KGaA Expands Distribution Deal with Roche (revised) Jan 17 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)